LEADD

LEADD performs goal-directed de novo molecular design to optimize molecular properties while enforcing synthetic feasibility.


Key Features:

  • Fragment-based molecular graphs: Represents molecules as graphs composed of molecular fragments.
  • Pairwise atom type compatibility rules: Uses knowledge-based pairwise atom type compatibility rules that constrain which bonds can form between fragments.
  • Reference library extraction: Extracts fragments from a reference library of drug-like molecules to derive compatibility rules.
  • Constraint-enforcing genetic operators: Implements novel genetic operators tailored to enforce compatibility constraints during evolution.
  • Lamarckian evolutionary mechanism: Adapts reproductive behavior of molecules dynamically based on fitness within the objective function.
  • Goal-directed optimization: Performs optimization of molecular properties under user-specified objective functions.
  • Benchmarked performance: Demonstrated improved fitness and predicted synthetic accessibility relative to virtual screening and other evolutionary algorithms on standardized benchmark suites.

Scientific Applications:

  • De novo drug discovery: Generates novel candidate molecules for drug discovery while prioritizing synthetic feasibility.
  • Property optimization: Optimizes key molecular properties (fitness metrics) in a goal-directed manner.
  • Synthetic accessibility-driven design: Produces molecules constrained by compatibility rules to enhance practical synthetic tractability.
  • Method comparison and benchmarking: Serves as a comparative approach against virtual screening and other evolutionary algorithms using standardized benchmark suites.

Methodology:

Represents molecules as fragment-based graphs; derives knowledge-based pairwise atom type compatibility rules from a reference library of drug-like molecules; applies novel genetic operators that enforce compatibility constraints within an evolutionary algorithm incorporating a Lamarckian adaptation of reproductive behavior; evaluated on standardized benchmark suites against virtual screening and other evolutionary algorithms.

Topics

Details

License:
GPL-3.0
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Linux
Programming Languages:
C++
Added:
6/17/2022
Last Updated:
6/17/2022

Operations

Data Inputs & Outputs

Publications

Kerstjens A, De Winter H. LEADD: Lamarckian evolutionary algorithm for de novo drug design. Journal of Cheminformatics. 2022;14(1). doi:10.1186/s13321-022-00582-y. PMID:35033209. PMCID:PMC8760751.

PMID: 35033209
PMCID: PMC8760751
Funding: - Fonds Wetenschappelijk Onderzoek: 39461